Biosecurity

Researchers identify potential vaccine for chlamydia

Chlamydia is a relatively common, treatable sexually transmitted infection, but because it often carries no symptoms, the potential for reproductive issues and blindness mean preventing its acquisition is good idea.

Researchers have identified an antigen with the potential to act as a vaccine against the STI, which could prevent health complications in people who have no idea they've contracted it, according to a new study conducted at McMaster University.

The U.S. Centers for Disease Control and Prevention estimates 2.86 million people infections occur annually but suggest there are many more than that because most people are asymptomatic and do not get tested.